David M. Loeb

6.2k citations

142 papers · 4.6k indexed · h-index 39

Impact in

Oncology top 2%
- CAR-T cell therapy research
Cancer Research top 5%
- Cancer Genomics and Diagnostics

Papers in

Hematology 24
- Hematopoietic Stem Cell Transplantation 17
- Acute Myeloid Leukemia Research 10
Oncology 50
- CAR-T cell therapy research 11

Co-authors: Lloyd A. Greene David R. Kaplan Robert M. Stephens Terry D. Copeland Tony Pawson Gregory McCarty Saraswati Sukumar Masanori Hayashi
Journals: Pediatric Blood & Cancer (11 papers)Biology of Blood and Marrow Transplantation (10 papers)Journal of Clinical Oncology (9 papers)Blood (8 papers)Journal of Pediatric Hematology/Oncology (7 papers)
Partner nations: United States Canada United Kingdom

In The Last Decade

David M. Loeb

135 papers receiving 4.6k citations

Peers

Countries citing papers authored by David M. Loeb

Since Specialization

Citations

This map shows the geographic impact of David M. Loeb's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David M. Loeb with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David M. Loeb more than expected).

Fields of papers citing papers by David M. Loeb

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by David M. Loeb. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David M. Loeb. The network helps show where David M. Loeb may publish in the future.

Co-authorship network

The 25 scholars most cited alongside David M. Loeb, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with David M. Loeb Line = papers co-authored together David M. Loeb links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	One-Carbon Metabolism Inhibition Depletes Purines and Results in Profound and Prolonged Ewing Sarcoma Growth Suppression Cancer Research Communications ·Adel Rahman, Fogarty, Gunter Behrmann, A.R.W. Forrest, Zhanjun Hou, Larry H. Matherly, David M. Loeb, Antonio Di Cristofano	2025	0
2	Polyamine Depletion by D,L-α-Difluoromethylornithine Inhibits Ewing Sarcoma Metastasis by Inducing Ferroptosis Clinical Cancer Research ·Bowyer Dj, Kyle W. Jackson, Masanori Hayashi, Jinghang Zhang, K Heira, Yuqi Tan, Tracy Murray Stewart, Paul Ciero, Jackson R. Foley, Robert A. Casero, Patrick Cahan, David M. Loeb	2025	1
3	Cytokine Release Syndrome and Arrhythmia After CAR-T Cell Therapy in a Pediatric Heart Transplant Recipient with Refractory PTLD The Journal of Heart and Lung Transplantation ·Nils Steuer, Eleanor Eckstein, Stefanie Reustlen, Anjan Dhar, Kyoung-Gon Oh, María Jesús Pérez-Granda, David M. Loeb, Daphne T. Hsu	2025	0
4	VISTA Emerges as a Promising Target against Immune Evasion Mechanisms in Medulloblastoma Cancers ·Д.А. Жуковский, 展周草野, Phillip M. Galbo, Алтынников Андрей Геннадиевич, Joanne Xiu, Kamalika Ghatak, Manus Dare, Å.H. Drotting, SIMON REICH, Soma Sengupta, Raj Chand, Charles G. Eberhart, David M. Loeb, Emad N. Eskandar, Deyou Zheng, Xingxing Zang, Allison Martin	2024	4
5	Atypical hemolytic uremic syndrome during induction chemotherapy in neuroblastoma, a rare phenomenon or common congenital predisposition? Pediatric Blood & Cancer ·贺俊花, Bowyer Dj, Michelle A. Lee, David M. Loeb, Deepa Manwani, William B. Mitchell, Daniel A. Weiser	2024	0
6	Tabelecleucel for EBV+ PTLD after allogeneic HCT or SOT in a multicenter expanded access protocol Blood Advances ·Sarah Nikiforow, Jennifer Whangbo, Ran Reshef, Donald E. Tsai, Nancy Bunin, Rolla Abu‐Arja, Kris M. Mahadeo, Wen‐Kai Weng, Koen van Besien, David M. Loeb, Sunita D. Nasta, Eneida R. Nemecek, Hans Michael Huck, Yan Sun, Jean N Labeque, Justin T. Wahlstrom, Aditi Mehta, Laurence Gamelin, Rajani Dinavahi, Susan E. Prockop	2024	8
7	Impact of race/ethnicity and language preferences on pediatric ALL survival outcomes Cancer Medicine ·贺俊花, Faradiba Salsabila, David M. Loeb, Melissa Fazzari, H. Dean Hosgood	2023	4
8	Breaking down the tumor immune infiltration within pediatric sarcomas Frontiers in Endocrinology ·Rachel Weil, David M. Loeb	2023	1
9	Acetophenone protection against cisplatin-induced end-organ damage Translational Oncology ·Brian C. Geohagen, Anna Dzierzek, Kimberly Reidy, Tao Wang, Evripidis Gavathiotis, Yonatan I. Fishman, Richard M. LoPachin, David M. Loeb, Daniel A. Weiser	2022	2
10	Circulating Plasma Tumor DNA Is Superior to Plasma Tumor RNA Detection in Ewing Sarcoma Patients Journal of Molecular Diagnostics ·Herrera Maria Lidia, Aron Hjartarson, M Nternal, V Hoenig, Hao Tang, Carrye Cost, Timothy Garrington, Brian Greffe, Sandra Luna‐Fineman, Jenna Sopfe, David M. Loeb, Masanori Hayashi	2021	9
11	XPO1 inhibition with selinexor synergizes with proteasome inhibition in neuroblastoma by targeting nuclear export of IkB Translational Oncology ·Ursula Wassermann, M Skoupý, Yosef Landesman, Bruce Pawel, 雅子堀口, Stephen R. Master, Kevin W. Freeman, David M. Loeb, Jean M. Hébert, Daniel A. Weiser	2021	20
12	Phase II trial of gemcitabine and nab‐paclitaxel in patients with recurrent Ewing sarcoma: A report from the National Pediatric Cancer Foundation Pediatric Blood & Cancer ·Javier Oesterheld, Damon R. Reed, Bhuvana A. Setty, Michael S. Isakoff, Patrick Thompson, Hong Yin, Masanori Hayashi, David M. Loeb, Tiffany Smith, Prajna Bhunia, Brooke L. Fridley, Lars M. Wagner	2020	16
13	An evolutionary framework for treating pediatric sarcomas Cancer ·Damon R. Reed, Pradyumna Vasudeo Desale, D Brătucu, Brooke L. Fridley, Masanori Hayashi, Michael S. Isakoff, David M. Loeb, Prajna Bhunia, Ryan D. Roberts, Matteo Trucco, Lars M. Wagner, Mark G. Alexandrow, Robert A. Gatenby, Joel S. Brown	2020	31
14	Strengths and Weaknesses of a Planar Whole-Body Method of ¹⁵³ Sm Dosimetry for Patients with Metastatic Osteosarcoma and Comparison with Three-Dimensional Dosimetry Cancer Biotherapy and Radiopharmaceuticals ·Donika Plyku, David M. Loeb, Andrew Prideaux, Sébastien Baechler, Richard L. Wahl, George Sgouros, Robert F. Hobbs	2015	9
15	Caspase-8 expression is predictive of tumour response to death receptor 5 agonist antibody in Ewing’s sarcoma British Journal of Cancer ·Zhigang Kang, Seth D. Goldstein, Yunkai Yu, Paul S. Meltzer, David M. Loeb, Liang Cao	2015	6
16	Population Pharmacokinetics of Bevacizumab in Children with Osteosarcoma: Implications for Dosing Clinical Cancer Research ·David C. Turner, Fariba Navid, Najat C. Daw, Shenghua Mao, Jianrong Wu, Victor M. Santana, Michael D. Neel, Bhaskar Rao, Jennifer Willert, David M. Loeb, Antonio García-Domínguez, Stacy L. Throm, Burgess B. Freeman, Yunita Yulia Benamen	2014	40
17	LGR5 is Expressed by Ewing Sarcoma and Potentiates Wnt/β-Catenin Signaling Frontiers in Oncology ·Christopher A. Scannell, Elisabeth A. Pedersen, Jack T. Mosher, Melanie A. Krook, Wenyi Xu, Breelyn A. Wilky, David M. Loeb, Elizabeth R. Lawlor	2013	35
18	Immunohistochemistry of affected tissue may guide cGVHD treatment decisions Bone Marrow Transplantation ·Kirsten M. Williams, Lyle W. Ostrow, David M. Loeb, Tae Chung, Ronald D. Cohn, Andrea M. Corse, Andrew L. Mammen, Allen Chen	2011	4
19	Tandem dosing of samarium‐153 ethylenediamine tetramethylene phosphoric acid with stem cell support for patients with high‐risk osteosarcoma Cancer ·David M. Loeb, Robert F. Hobbs, Dwayne Surles, Allen Chen, Steve Cho, Srinivasan Senthamizhchelvan, George Sgouros, Ori Shokek, Moody D. Wharam, Tammy Scott, Cindy L. Schwartz	2010	16
20	WT1 Influences Apoptosis Through Transcriptional Regulation of Bcl-2 Family Members Cell Cycle ·David M. Loeb	2006	46

About David M. Loeb

David M. Loeb is a scholar working on Hematology, Oncology, Pulmonary and Respiratory Medicine, Pathology and Forensic Medicine and Cancer Research, having authored 142 papers that have together received 4.6k indexed citations. Recurring topics across this work include Sarcoma Diagnosis and Treatment (37 papers), Renal and related cancers (19 papers), Hematopoietic Stem Cell Transplantation (17 papers), Cancer Genomics and Diagnostics (11 papers), CAR-T cell therapy research (11 papers), Acute Lymphoblastic Leukemia research (11 papers), Acute Myeloid Leukemia Research (10 papers) and Neuroblastoma Research and Treatments (10 papers). The work is most often cited by research in Oncology (1.2k citations), Cancer Research (620 citations), Cellular and Molecular Neuroscience (711 citations), Pulmonary and Respiratory Medicine (1.3k citations) and Developmental Neuroscience (154 citations). David M. Loeb has collaborated with scholars based in United States, Canada and United Kingdom. Frequent co-authors include Lloyd A. Greene, David R. Kaplan, Robert M. Stephens, Terry D. Copeland, Tony Pawson, Gregory McCarty, Saraswati Sukumar, Masanori Hayashi, Dorian Korz and Ella Evron. Their work appears in journals such as Pediatric Blood & Cancer, Biology of Blood and Marrow Transplantation, Journal of Clinical Oncology, Blood and Journal of Pediatric Hematology/Oncology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact